PC

Prudhvi Chirala

Active Director Managing Director DIN 09531665
DIN 09531665 First appointment Mar 2022 Primary industry Food And Beverages
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Prudhvi Chirala

Data last updated:

Prudhvi Chirala is a Managing Director at Stankhardt Pharmaceuticals Private Limited (since 2022). The company operates in Food And Beverages.

DIN 09531665
Primary Designation Managing Director
Industry Food And Beverages
First Appointment 09 Mar 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Managing Director09 Mar 20222022Active

Board colleagues of Prudhvi Chirala

NameDINCompanyDesignation
Thrinath Chirala10483531Stankhardt Pharmaceuticals Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Stankhardt Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Prudhvi Chirala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prudhvi Chirala

Prudhvi Chirala currently holds 1 directorship: Stankhardt Pharmaceuticals Private Limited (Managing Director, since 09 Mar 2022).

Prudhvi Chirala was first appointed on 09 Mar 2022 as Managing Director at Stankhardt Pharmaceuticals Private Limited.

The current boards of Prudhvi Chirala's companies include Thrinath Chirala (Stankhardt Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available